<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30174721</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1754-6605</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>12</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Ecancermedicalscience</Title>                <ISOAbbreviation>Ecancermedicalscience</ISOAbbreviation>            </Journal>            <ArticleTitle>Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis.</ArticleTitle>            <Pagination>                <MedlinePgn>859</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3332/ecancer.2018.859</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">Previous studies have reported that psychological and social distresses associated with a cancer diagnosis have led to an increase in suicides compared to the general population. We sought to explore lung cancer-associated suicide rates in a large national database compared to the general population, and to the three most prevalent non-skin cancers [breast, prostate and colorectal cancer (CRC)].</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The Surveillance, Epidemiology and End Results (SEER) database (1973-2013) was retrospectively reviewed to identify cancer-associated suicide deaths in all cancers combined, as well as for each of lung, prostate, breast or CRCs. Suicide incidence and standardised mortality ratio (SMR) were estimated using SEER*Stat-8.3.2 program. Suicidal trends over time and timing from cancer diagnosis to suicide were estimated for each cancer type.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among 3,640,229 cancer patients, 6,661 committed suicide. The cancer-associated suicide rate was 27.5/100,000 person years (SMR = 1.57). The highest suicide risk was observed in patients with lung cancer (SMR = 4.17) followed by CRC (SMR = 1.41), breast cancer (SMR = 1.40) and prostate cancer (SMR = 1.18).Median time to suicide was 7 months in lung cancer, 56 months in prostate cancer, 52 months in breast cancer and 37 months in CRC (<i>p</i> &lt; 0.001).We noticed a decreasing trend in suicide SMR over time, which is most notable for lung cancer compared to the other three cancers. In lung cancer, suicide SMR was higher in elderly patients (70-75 years; SMR = 12), males (SMR = 8.8), Asians (SMR = 13.7), widowed patients (SMR = 11.6), undifferentiated tumours (SMR = 8.6), small-cell lung cancer (SMR = 11.2) or metastatic disease (SMR = 13.9) and in patients who refused surgery (SMR = 13).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The cancer-associated suicide rate is nearly twice that of the general population of the United States of America. The suicide risk is highest among the patients with lung cancer, particularly elderly, widowed, male patients and patients with unfavourable tumour characteristics. The identification of high-risk patients is of extreme importance to provide proper psychological assessment, support and counselling to reduce these rates.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rahouma</LastName>                    <ForeName>Mohamed</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kamel</LastName>                    <ForeName>Mohamed</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Abouarab</LastName>                    <ForeName>Ahmed</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Eldessouki</LastName>                    <ForeName>Ihab</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Vontz Molecular Center, Hemato-oncology Department, University of Cincinnati, Cincinnati, OH 45220, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nasar</LastName>                    <ForeName>Abu</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Harrison</LastName>                    <ForeName>Sebron</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Benjamin</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shostak</LastName>                    <ForeName>Eugene</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morris</LastName>                    <ForeName>John</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Vontz Molecular Center, Hemato-oncology Department, University of Cincinnati, Cincinnati, OH 45220, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stiles</LastName>                    <ForeName>Brendon</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Altorki</LastName>                    <ForeName>Nasser K</ForeName>                    <Initials>NK</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Port</LastName>                    <ForeName>Jeffrey L</ForeName>                    <Initials>JL</Initials>                    <AffiliationInfo>                        <Affiliation>Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 14853 USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Ecancermedicalscience</MedlineTA>            <NlmUniqueID>101392236</NlmUniqueID>            <ISSNLinking>1754-6605</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Psychiatry Rev. 2012 Aug 1;8(3):247-256</RefSource>                <PMID Version="1">23990808</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2018 May 18;:null</RefSource>                <PMID Version="1">29777570</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Patient Educ Couns. 2003 Jun;50(2):179-86</RefSource>                <PMID Version="1">12781933</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2012 Apr 5;366(14):1310-8</RefSource>                <PMID Version="1">22475594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Epidemiol. 1989 Nov;130(5):1024-32</RefSource>                <PMID Version="1">2683747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2015 Apr;35(4):2215-21</RefSource>                <PMID Version="1">25862881</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Oct 10;26(29):4720-4</RefSource>                <PMID Version="1">18695256</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Jun 15;122(12):1937-45</RefSource>                <PMID Version="1">27070342</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2000 Oct;36(15):1938-43</RefSource>                <PMID Version="1">11000574</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Rev Psychiatry. 2014 Feb;26(1):16-30</RefSource>                <PMID Version="1">24716498</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Future Oncol. 2016 Dec;12(24):2823-2834</RefSource>                <PMID Version="1">27467398</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2015 May;24(5):601-7</RefSource>                <PMID Version="1">25336020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):483-7</RefSource>                <PMID Version="1">25015541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Nurs. 2012 Jul-Aug;35(4):E14-26</RefSource>                <PMID Version="1">21946906</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Suicide Life Threat Behav. 1988 Fall;18(3):219-36</RefSource>                <PMID Version="1">3188138</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Public Health. 2001 Jan;91(1):150-3</RefSource>                <PMID Version="1">11189813</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst Monogr. 2004;(32):9-16</RefSource>                <PMID Version="1">15263035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2005 Mar 28;92(6):995-1000</RefSource>                <PMID Version="1">15756279</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2017 Mar;26(3):337-345</RefSource>                <PMID Version="1">27167009</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ Open. 2014 Mar 13;4(3):e003901</RefSource>                <PMID Version="1">24625637</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2016 Jan 26;315(4):380-7</RefSource>                <PMID Version="1">26813211</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2018 May;27(5):1450-1456</RefSource>                <PMID Version="1">29055289</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2004 May 15;22(10):1849-56</RefSource>                <PMID Version="1">15143077</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2011 Oct;50(7):1037-44</RefSource>                <PMID Version="1">21861596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2004 Oct 15;22(20):4209-16</RefSource>                <PMID Version="1">15483032</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asia Pac J Public Health. 1995;8(3):181-5</RefSource>                <PMID Version="1">10050186</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Rev Psychiatry. 2014 Feb;26(1):31-43</RefSource>                <PMID Version="1">24716499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chest. 2013 Oct;144(4):1245-1252</RefSource>                <PMID Version="1">23681288</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2015 Feb;35(2):941-7</RefSource>                <PMID Version="1">25667478</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2018 Apr;27(4):1298-1304</RefSource>                <PMID Version="1">29453797</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">SEER database</Keyword>            <Keyword MajorTopicYN="N">lung cancer</Keyword>            <Keyword MajorTopicYN="N">psychological support</Keyword>            <Keyword MajorTopicYN="N">standardised mortality ratio (SMR)</Keyword>            <Keyword MajorTopicYN="N">suicide</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30174721</ArticleId>            <ArticleId IdType="doi">10.3332/ecancer.2018.859</ArticleId>            <ArticleId IdType="pii">can-12-859</ArticleId>            <ArticleId IdType="pmc">PMC6113987</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>